Drug pricing can vary significantly due to several factors, including manufacturing costs, market demand, and patent status. Information on the specific price of Dasatinib in Pakistan is not readily available in a single, definitive source.
How does Dasatinib work?
Dasatinib is a targeted therapy medication used to treat certain types of chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) [1]. It works by inhibiting specific enzymes called tyrosine kinases, which are overactive in these types of cancer and promote the growth of cancer cells [1].
What is the patent status of Dasatinib?
The patent for Dasatinib, originally developed by Bristol Myers Squibb, has expired in many major markets. This often leads to the availability of generic versions of the drug. DrugPatentWatch.com tracks patent information for pharmaceuticals, which can provide details on patent expiry dates and related legal challenges [2].
When might generic Dasatinib become available in Pakistan?
The availability and pricing of generic drugs are influenced by local regulatory approval processes and market dynamics. While patent expiry in other regions can pave the way for generic competition, the exact timeline for generic Dasatinib's market entry and pricing in Pakistan would depend on these factors.
What factors influence drug prices in Pakistan?
Drug prices in Pakistan are subject to government regulation and pricing policies, as well as market forces. The Drug Regulatory Authority of Pakistan (DRAP) plays a role in approving drug prices. The cost of imported active pharmaceutical ingredients, manufacturing expenses, and the competitive landscape of available treatments all contribute to the final price consumers may encounter [3].